Definitive Additional Materials

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of

the Securities Exchange Act of 1934

(Amendment No.     )

 

 

Filed by the Registrant  ☒                            Filed by a Party other than the Registrant  ☐

Check the appropriate box:

 

  Preliminary Proxy Statement
  Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
  Definitive Proxy Statement
  Definitive Additional Materials
  Soliciting Material under Rule 14a-12

Tenet Healthcare Corporation

(Name of Registrant as Specified in Its Charter)

Payment of Filing Fee (Check the appropriate box):

 

  No fee required.
  Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
  (1)  

Title of each class of securities to which transaction applies:

 

     

  (2)  

Aggregate number of securities to which transaction applies:

 

     

  (3)  

Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined):

 

     

  (4)  

Proposed maximum aggregate value of transaction:

 

     

  (5)  

Total fee paid:

 

     

  Fee paid previously with preliminary materials.
  Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
  (1)  

Amount Previously Paid:

 

     

  (2)  

Form, Schedule or Registration Statement No.:

 

     

  (3)  

Filing Party:

 

     

  (4)  

Date Filed:

 

     

 

 

 


*** Exercise Your Right to Vote ***

Important Notice Regarding the Availability of Proxy Materials for the

Shareholder Meeting to Be Held on May 04, 2017

 

 

     TENET HEALTHCARE CORPORATION
        LOGO
    

 

TENET HEALTHCARE CORPORATION

     1445 ROSS AVENUE
     SUITE 1400
     DALLAS, TX 75202
LOGO     
           
   

 

Meeting Information

   
 

 

  Meeting Type: Annual Meeting

   
 

 

  For holders as of: March 13, 2017

   
 

 

  Date: May 04, 2017            Time: 8:00 AM CDT

   
 

 

  Location:

 

 

 Tenet Corporate Headquarters

   
   

 

 1445 Ross Avenue, Suite 1400

   
     

 

 Dallas, Texas 75202

 

   

 

 

 

 
 

 

You are receiving this communication because you hold shares in the above named company.

 
 

This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side).

 
 

We encourage you to access and review all of the important information contained in the proxy materials before voting.

 

 
 

See the reverse side of this notice to obtain  proxy materials and voting instructions.

 

 
 


Before You Vote

How to Access the Proxy Materials

 

     Proxy Materials Available to VIEW or RECEIVE:    
    

 

1. Notice & Proxy Statement         2. Form 10-K

 

How to View Online:

Have the information that is printed in the box marked by the arrow LOGO (located on the following page) and visit: www.proxyvote.com.

 

How to Request and Receive a PAPER or E-MAIL Copy:

 

If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:

 

1) BY INTERNET:         www.proxyvote.com

2) BY TELEPHONE:     1-800-579-1639

3) BY E-MAIL*:             sendmaterial@proxyvote.com

 

*  If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked by the arrow LOGO (located on the following page) in the subject line.

 

Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before April 20, 2017 to facilitate timely delivery.

 

   
        
        
        
        
        
        
        
        
        
        
      

 

How To Vote

Please Choose One of the Following Voting Methods

 

               

LOGO

      

 

Vote In Person: Many shareholder meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares.

 

Vote By Internet: To vote now by Internet, go to www.proxyvote.com. Have the information that is printed in the box marked by the arrow LOGO available and follow the instructions.

 

Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.

 

   
          
          
          
          
          
          
               


  Voting items     
 

 

The Board of Directors recommends you vote FOR the following:

  1.    Election of Directors     
     Nominees     
  1A    John P. Byrnes     
  1B    Trevor Fetter     
  1C    Brenda J. Gaines     
  1D    Karen M. Garrison     
  1E    Edward A. Kangas     
  1F    J. Robert Kerrey     
  1G    Richard R. Pettingill     
  1H    Matthew J. Ripperger     
  1I    Ronald A. Rittenmeyer     
LOGO       1J    Tammy Romo     
 

 

1K

  

 

Randolph C. Simpson

    
 

 

1L

  

 

Peter M. Wilver

    
 

 

The Board of Directors recommends you vote FOR the following proposal:

 

 

2.

  

 

Proposal to approve, on an advisory basis, the company’s executive compensation.

  
  

 

The Board of Directors recommends you vote 1 YEAR on the following proposal:

3.    Proposal to approve, on an advisory basis, the option of every “1 year”, “2 years” or “3 years” for future advisory votes on executive compensation.
The Board of Directors recommends you vote FOR proposals 4. and 5.
4.    Proposal to approve the material terms of the performance goals under the Third Amended Tenet Healthcare Corporation Annual Incentive Plan.
5.    Proposal to ratify the selection of Deloitte & Touche as independent registered public accountants for the year ending December 31, 2017.
NOTE: Such other business as may properly come before the meeting or any adjournment thereof.
 


 

 

 

 

 

 

 

LOGO